Loading clinical trials...
Loading clinical trials...
Pyruvate Kinase Deficiency Global Longitudinal Registry: Patient-Reported Outcomes
Conditions
Locations
5
United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Milan, Italy
Universitair Medisch Centrum Utrecht
Utrecht, Netherlands
Hospital Infantil Universitario Niño Jesus - PIN
Madrid, Spain
Hammersmith Hospital
London, United Kingdom
Start Date
July 2, 2021
Primary Completion Date
June 30, 2023
Completion Date
June 30, 2023
Last Updated
September 7, 2023
NCT05012111
NCT03520647
NCT05447442
NCT06287268
NCT04645199
NCT03050268
Lead Sponsor
Agios Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions